Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The incidence of papillary thyroid carcinoma (PTC) has been increasing worldwide in recent years. Therefore, novel potential therapeutic targets for PTC are urgently needed. Enhancer of zeste homolog 2 (EZH2), a methyltransferase belonging to PRC2, plays important roles in epigenetic silencing and cell cycle regulation. | EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma